Bio-Connect
The figure shows a typical standard curve for the soluble SEMA4D ELISA. The immunoassay is calibrated against recombinant human Semaphorin 4D.
The figure shows a typical standard curve for the soluble SEMA4D ELISA. The immunoassay is calibrated against recombinant human Semaphorin 4D.
The figure shows a typical standard curve for the soluble SEMA4D ELISA. The immunoassay is calibrated against recombinant human Semaphorin 4D.

Human soluble Semaphorin 4D ELISA

Research Use Only
BI-20405
Biomedica
Assay Sample TypeEDTA plasma, citrate plasma, heparın plasma, cell culture supernatant
Product group Assays
€ 827,00
96 tests
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Biomedica
  • Product Name
    Human soluble Semaphorin 4D ELISA
  • Delivery Days Customer
    7
  • Assay Detection Range
    0 – 2 000 pmol/l (= 0 – 157.8 ng/ml)
  • Assay Precision
    In-between-run (n=11): ≤ 11 % CV. Within-run (n=5): ≤ 8 % CV
  • Assay Sample Type
    EDTA plasma, citrate plasma, heparın plasma, cell culture supernatant
  • Assay Sensitivity
    12 pmol/l (= 0.94 ng/ml)
  • Assay Specificity
    Endogenous and recombinant human soluble Semaphorin 4D.
  • Assay Test Principle
    This Smephorin 4D ELISA kit is a sandwich enzyme immunoassay for the quantitative determination of soluble Semaphorin 4D in human plasma and cell culture supernatant.
  • Assay Time
    3 h / 1 h / 30 min
  • Certification
    Research Use Only
  • Scientific Description
    The Semaphorin 4D ELISA kit is a 4.5 hour, 96-well sandwich ELISA for the quantitative determination of soluble Sempahorin 4D (SEMA4D) in EDTA plasma, citrate plasma, heparın plasma and cell culture supernatant. The assay employs human plasma-based standards to ensure the measurement of biologically reliable data. The soluble SEMA4D ELISA kit uses highly purified, epitope mapped antibodies. The antibodies utilized in the soluble Semaphorin-4D ELISA kit bind to AA30-AA34 and AA238-AA214 of soluble Semaphorin 4D.
  • UNSPSC
    41116133

References

  • Aberer F, Pferschy PN, Tripolt NJ, et al. Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study. Diabetes Obes Metab. 2020;22(2):212-221.
    Read more